Xpan is bringing to market the next standard of care of minimally invasive surgical access products (tubular port aka trocars). Xpan's FDA-cleared revolutionary trocar that is smaller and radially expandable (compared to fixed-diameter trocars on the market). Xpan's product will simplify surgery while significantly reducing cost and safety issues. The company is performing first-in-man evaluations in Q4 in the US, and is interested in connecting with potential customers and distribution partners.

Event details

Date: October 9 - 11, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


13 in total